AU567018B2 - Prazosin-pirbuterol combination for bronchoduation - Google Patents

Prazosin-pirbuterol combination for bronchoduation

Info

Publication number
AU567018B2
AU567018B2 AU64832/86A AU6483286A AU567018B2 AU 567018 B2 AU567018 B2 AU 567018B2 AU 64832/86 A AU64832/86 A AU 64832/86A AU 6483286 A AU6483286 A AU 6483286A AU 567018 B2 AU567018 B2 AU 567018B2
Authority
AU
Australia
Prior art keywords
pirbuterol
prazosin
pharmaceutically acceptable
bronchoduation
combination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU64832/86A
Other languages
English (en)
Other versions
AU6483286A (en
Inventor
Craig A.P.D. Saxton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp SRL
Original Assignee
Pfizer Corp Belgium
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Corp Belgium, Pfizer Inc filed Critical Pfizer Corp Belgium
Publication of AU6483286A publication Critical patent/AU6483286A/en
Application granted granted Critical
Publication of AU567018B2 publication Critical patent/AU567018B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU64832/86A 1985-11-06 1986-11-05 Prazosin-pirbuterol combination for bronchoduation Ceased AU567018B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/795,689 US4601897A (en) 1985-11-06 1985-11-06 Prazosin-pirbuterol combination for bronchodilation
US795689 1985-11-06

Publications (2)

Publication Number Publication Date
AU6483286A AU6483286A (en) 1987-05-21
AU567018B2 true AU567018B2 (en) 1987-11-05

Family

ID=25166193

Family Applications (1)

Application Number Title Priority Date Filing Date
AU64832/86A Ceased AU567018B2 (en) 1985-11-06 1986-11-05 Prazosin-pirbuterol combination for bronchoduation

Country Status (14)

Country Link
US (1) US4601897A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP0222575B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPS62135424A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) ATE59295T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU567018B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1284107C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE3676640D1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK527186A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES2036174T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GR (1) GR3001420T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IE (1) IE59327B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL80476A0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NZ (1) NZ218175A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA868427B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4868182A (en) * 1986-11-05 1989-09-19 Merrell Dow Pharmaceuticals Inc. Enhancement of prazosin
ZA878182B (en) * 1986-11-05 1988-05-02 Merrell Dow Pharmaceuticals Inc. Enhancement of prazosin
US5110927A (en) * 1987-12-31 1992-05-05 The United States Of America As Represented By The Department Of Health And Human Services Prazosin analog with increased selectivity and duration of action
US5225183A (en) * 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
US5776434A (en) 1988-12-06 1998-07-07 Riker Laboratories, Inc. Medicinal aerosol formulations
US6048857A (en) * 1989-10-17 2000-04-11 Ellinwood, Jr.; Everett H. Dosing method of administering medicaments via inhalation administration
US5439670A (en) * 1989-11-28 1995-08-08 Riker Laboratories, Inc. Medicinal aerosol formulations
US5503869A (en) * 1994-10-21 1996-04-02 Glaxo Wellcome Inc. Process for forming medicament carrier for dry powder inhalator
JP2008535924A (ja) * 2005-04-12 2008-09-04 エラン ファーマ インターナショナル リミテッド ナノ粒子キナゾリン誘導体製剤

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1635776A (en) * 1975-08-08 1977-09-29 Nissan Motor Company Limited A method of forming a cylinder head and core unit therefor
AU3781878A (en) * 1977-08-04 1980-01-10 Abbott Laboratories 1 (4-amino-6, 7-dimethoxy-2-quinazolinyl) 4 (2 tetrahydrofuroyl) piperazine hydrochloride dihydrate

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3517005A (en) * 1967-10-26 1970-06-23 Pfizer & Co C Certain 2- and 4-substituted quinazolines
US3511836A (en) * 1967-12-13 1970-05-12 Pfizer & Co C 2,4,6,7-tetra substituted quinazolines
US3723434A (en) * 1970-07-17 1973-03-27 Pfizer Piperazino isoquinoline bronchodilators
US3786160A (en) * 1971-02-16 1974-01-15 Pfizer Use of 2-hydroxymethyl-3-hydroxy-6-(1-hydroxy-2-aminoethyl)-pyridines as bronchodilators
US3700681A (en) * 1971-02-16 1972-10-24 Pfizer 2-hydroxymethyl-3-hydroxy-6-(1-hydroxy-2-aminoethyl)pyridines
US4092315A (en) * 1976-03-01 1978-05-30 Pfizer Inc. Novel crystalline forms of prazosin hydrochloride
US4175128A (en) * 1979-01-03 1979-11-20 Pfizer Inc. Method for treating congestive heart failure
FI67699C (fi) * 1979-01-31 1985-05-10 Orion Yhtymae Oy Foerfarande foer framstaellning av 6,7-dimetoxi-4-amino-2-(4-(2-furoyl)-1-piperazinyl)kinazolinhydroklorid med blodtryckssaenkande verkan
DE3235565A1 (de) * 1982-09-25 1984-03-29 Boehringer Ingelheim KG, 6507 Ingelheim Piperidinderivate, ihre herstellung und verwendung

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1635776A (en) * 1975-08-08 1977-09-29 Nissan Motor Company Limited A method of forming a cylinder head and core unit therefor
AU3781878A (en) * 1977-08-04 1980-01-10 Abbott Laboratories 1 (4-amino-6, 7-dimethoxy-2-quinazolinyl) 4 (2 tetrahydrofuroyl) piperazine hydrochloride dihydrate

Also Published As

Publication number Publication date
IE862911L (en) 1987-05-06
JPH0524890B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1993-04-09
EP0222575B1 (en) 1990-12-27
US4601897A (en) 1986-07-22
ATE59295T1 (de) 1991-01-15
JPS62135424A (ja) 1987-06-18
NZ218175A (en) 1989-04-26
EP0222575A1 (en) 1987-05-20
DK527186D0 (da) 1986-11-05
GR3001420T3 (en) 1992-09-25
DK527186A (da) 1987-05-07
IL80476A0 (en) 1987-02-27
ZA868427B (en) 1988-06-29
AU6483286A (en) 1987-05-21
DE3676640D1 (de) 1991-02-07
ES2036174T3 (es) 1993-05-16
CA1284107C (en) 1991-05-14
IE59327B1 (en) 1994-02-09

Similar Documents

Publication Publication Date Title
BG103417A (en) Condensed pyrimidine bicyclic derivatives
AU561016B2 (en) N-glycosylated carboxamide derivatives
HUT47217A (en) Process for producing pharmaceutical compositions containing indol derivatives as active components
MY103850A (en) Phenol substituted gem-diphosphonate derivatives, process for their preparation and pharmaceutical compositions containing them.
CA2029420A1 (en) Pharmaceutical compositions and methods for inhibition of maillard's reaction
AU1331588A (en) Method for treatment of alcohol abuse
IL102814A0 (en) Pyrazine derivatives,their preparation and pharmaceutical compositions comprising them
HU913010D0 (en) Method for producing inhibitors of calcium ingestion
DE69802113D1 (de) Zusammensetzungen zur erhöhung der konzentration und/oder beweglichkeit von samenzellen in menschen
AU567018B2 (en) Prazosin-pirbuterol combination for bronchoduation
DE3166084D1 (en) Tricyclic cytosine derivatives for use in pharmaceutical preparations and process for their preparation
ES555118A0 (es) Metodo de preparar medicamentos que incluyen un agente buscador de hueso y un inhibidor de anhidrasa carbonica, para impedir y curar enfermedades oseas.
EP0339549A3 (en) Tyr-peptide analogs
AU611113B2 (en) Basically substituted phenylacetonitriles, their preparation and drugs containing these compounds
DE3361990D1 (en) Alkylene-bridged guanidino-thiazole derivatives, method for their preparation and their use as medicaments
ES8400742A1 (es) Procedimiento de preparacion de las dibenzooxepinas sustituidas y de sus sales de adicion con un acido mineral u organi-co.
CA2063273A1 (en) Surfactant compositions and methods
NZ215480A (en) Polyprenyl compounds and compositions
HUT59100A (en) Process for producing acetylene derivatives of calcium-absorbtion inhibiting activity and pharmaceutical compositions containing them
GR3033649T3 (en) Growth factor compositions, preparation and use.
EP0386920A3 (en) 2-hydroxy-3-thienyloxypropylamino derivatives
ES2064652T3 (es) Derivados de naftaleno- y tetrahidronaftaleno-gem-difosfonato.
EP0255141A3 (en) Combination of active agents comprising diltiazem and acetylsalicylic acid, their preparation as well as their use in the preparation of medicaments with a thrombocyte-aggregation inhibitory activity
ZA843615B (en) 2-alkylthio-1-aminoalkyl-2-pyrroline-3-carbonitriles,processes for their preparation,as well as their use in the prophylaxis and therapy of thrombotic states
IT1245390B (it) Composizione farmaceutica ad attivita' antivirale